Neovascular growth following photodynamic therapy for choroidal hemangioma and neovascular regression after intravitreous injection of triamcinolone.
Leys
Anita M
AM
Department of Ophthalmology, University Hospitals, Leuven, Belgium.
Silva
Rufino
R
Inhoffen
Werner
W
Tatar
Olcay
O
D000293:Adolescent; D000328:Adult; D002830:Choroid Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D004396:Coloring Agents; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use*; D006391:Hemangioma / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007208:Indocyanine Green; D007267:Injections; D008297:Male; D010778:Photochemotherapy / Q000009:adverse effects*; D017319:Photosensitizing Agents / Q000009:adverse effects; D011166:Porphyrins / Q000009:adverse effects; D012008:Recurrence; D015861:Retinal Neovascularization / Q000139:chemically induced* / Q000188:drug therapy* / Q000503:physiopathology; D019233:Retreatment; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D000077362:Verteporfin; D014822:Vitreous Body
D004396:Coloring Agents; D005938:Glucocorticoids; D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin; D014222:Triamcinolone Acetonide; D007208:Indocyanine Green